Most patients in the Roberts et al. study were diagnosed with generalized anxiety disorder (GAD); responders showed a nonstatistically significant increase in SERT methylation, while nonresponders showed a significant decrease in methylation (p = 0.037). Here, SLC6A4 is linked to generalized anxiety disorder.